Elucid

About:

Elucid enables precision medicine for cardiovascular disease by applying A.I to medical image analysis validated against true biology.

Website: http://elucid.com

Twitter/X: ElucidBio

Top Investors: National Science Foundation, Elevage Medical Technologies, IAG Capital Partners, Aphelion Capital, Bioverge

Description:

Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, ElucidVivo, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from a single CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services.